Beckman Coulter, Wyatt Technology Partner
News Mar 04, 2014
Beckman Coulter Life Sciences announced an agreement with Wyatt Technology Corporation enabling collaboration on products, applications and technical development. The partnership brings together Wyatt’s expertise in protein characterization, light scattering and biophysics with Beckman Coulter’s expertise in particle counting, particle characterization and cell viability measurement.
“We are excited to be working with Wyatt Technology, as they have strong brand recognition in sectors such as biopharmaceuticals. Their products are already known by our Vi-Cell and analytical ultracentrifuge customers,” said Matt Rhyner, PhD, senior marketing manager, Beckman Coulter Life Sciences. “Partnering with Wyatt Technology, a storied company renowned for their technology and products, will help us expand our portfolio and presence in the particle market.”
The accord specifies that the companies will develop products for nanoparticle characterization to be marketed under the Beckman Coulter Life Sciences brand, and opens the door for future collaborations on product development and the sharing of business practices.
“Collaboration with Beckman Coulter has been of interest since getting to know Wallace Coulter in the late 1970s,” explained Dr. Philip Wyatt, chief executive officer, Wyatt Technology. “Entering into this agreement with a company that has the history and strong product portfolio of Beckman Coulter, we see a great opportunity to expand market access while retaining the strength and character upon which our customers rely.”
Taken together with the recent addition of the MET ONE and HIAC brands, the accord with Wyatt enables Beckman Coulter to provide a greater range of particle characterization solutions and to further enhance their world-class customer support and service.
Currently being introduced at Pittcon 2014 Booth 1964, the Multisizer 4e COULTER COUNTER is the latest Beckman Coulter innovation in particle counting and characterization, measuring particles as small as 0.2 microns.
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.